Back

Interleukin-22–STAT3 Signaling Preserves Structural Integrity in the Pressure-Overloaded Right Ventricle

28 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension: pre-clinical Pathophysiology and Mechanisms ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kodai Shibao

Kurume University, Kurume (Japan)

5 More presentations in this session

Presentation thumbnail
Insulin resistance genetic susceptibility drives pulmonary arterial hypertension through monocyte metabolic reprogramming and immune dysregulation
Mr S. Hou (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Prophylactic ranolazine and trimetazidine attenuate right ventricular dysfunction and improve exercise capacity in experimental pulmonary hypertension
Doctor A. Oz (Istanbul, TR) Miss S. Asal (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Empagliflozin attenuates pulmonary vascular hemodynamic progression and improves right ventricular adaptation in overcirculation-induced pulmonary hypertension
Doctor A. Garcia-Alvarez (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Myo-inositol trispyrophosphate improves oxygen delivery and right ventricular function in rat pressure overload model
Doctor M. Maczewski (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Targeting the PSMB9–NGAL/MMP9 Axis: a novel neutrophil-driven mechanism and precision target for vascular remodeling in PAH
Associate Professor X. He (Guangzhou, CN)
Abstract Slides

Access the full session

Session thumbnail
Pulmonary hypertension: pre-clinical

The Event

Event poster

ESC Congress 2026

28 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
A new mechanism of right ventricular remodeling by Interleukin-22 under right ventricular pressure overload
30 August 2025
thumbnail
Congress Presentation
Immune–metabolic crosstalk between T cells and interstitial macrophages drives pulmonary vascular remodeling in cardiometabolic HFpEF
28 August 2026
thumbnail
Congress Presentation
Co-targeting fibroblast mechanotransduction and cardiomyocyte metabolism wtih a Src family kinase inhibitor as a strategy to treat heart failure
29 August 2026
thumbnail
Congress Presentation
Right ventricular diastolic dysfunction across experimental disease models: unpacking diversity beyond pulmonary hypertension - a systematic review
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources